IP Library › Assignment 056259/0713
Patent Assignment
Reel/Frame 056259/0713

Assignment of Assignor's Interest

Recorded: 2021-05-17 Pages: 6
Assignor
TABUTEAU, HERRIOT
Executed: 2021-04-29
Assignee
AXSOME THERAPEUTICS, INC.
22 CORTLANDT STREET, 16TH FLOOR, NEW YORK, NEW YORK, 10007
Covered Properties (8)
Use of Reboxetine to Treat Narcolepsy
Application: 17/116,874 →
Publication: US US20210100808A1
Pharmaceutical Compositions Comprising Meloxicam
Application: 63/133,125 →
Pharmaceutical Compositions Comprising Meloxicam
Application: 17/145,744 →
Publication: US US20210128575A1
Methods of Modulating Tetrabenazine Metabolites Plasma Levels Using Bupropion
Application: 17/158,464 →
Publication: US US20210145770A1
Pharmaceutical Compositions Comprising Meloxicam
Application: 17/165,274 →
Publication: US US20210154299A1
Use of Reboxetine to Treat Narcolepsy
Application: 17/177,554 →
Publication: US US20210169893A1
Dosage Forms and Methods for Enantiomerically Enriched or Pure Bupropion
Application: 17/183,645 →
Publication: US US20210196704A1
Pharmaceutical Compositions Comprising Meloxicam
Application: 17/205,936 →
Publication: US US20210228592A1
Related Assignments (2)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Feb 24, 2021
From: TABUTEAU, HERRIOT
To: AXSOME THERAPEUTICS, INC.
Reel/Frame 055388/0349 →
Security Interest May 9, 2025
From: AXSOME THERAPEUTICS, INC.; AXSOME MALTA LTD.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 071247/0836 →